Ultravate is a brand name of halobetasol topical, approved by the FDA in the following formulation(s):
ULTRAVATE (halobetasol propionate - cream; topical)
Manufacturer: RANBAXY
Approval date: December 27, 1990
Strength(s): 0.05% [RLD][AB]
ULTRAVATE (halobetasol propionate - ointment; topical)
Manufacturer: RANBAXY
Approval date: December 17, 1990
Strength(s): 0.05% [RLD][AB]
Has a generic version of Ultravate been approved?
Yes. The following products are equivalent to Ultravate:
halobetasol propionate cream; topical
Manufacturer: FOUGERA PHARMS
Approval date: December 16, 2004
Strength(s): 0.05% [AB]
Manufacturer: G AND W LABS
Approval date: April 24, 2007
Strength(s): 0.05% [AB]
Manufacturer: PERRIGO ISRAEL
Approval date: December 16, 2004
Strength(s): 0.05% [AB]
Manufacturer: TARO
Approval date: August 4, 2005
Strength(s): 0.05% [AB]
halobetasol propionate ointment; topical
Manufacturer: FOUGERA PHARMS
Approval date: December 16, 2004
Strength(s): 0.05% [AB]
Manufacturer: G AND W LABS
Approval date: September 7, 2006
Strength(s): 0.05% [AB]
Manufacturer: PERRIGO
Approval date: December 16, 2004
Strength(s): 0.05% [AB]
Manufacturer: TARO
Approval date: December 16, 2004
Strength(s): 0.05% [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ultravate. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Ultravate.
See also...
- Ultravate Cream Consumer Information (Wolters Kluwer)
- Ultravate Consumer Information (Cerner Multum)
- Ultravate Advanced Consumer Information (Micromedex)
- Halobetasol Cream Consumer Information (Wolters Kluwer)
- Halobetasol topical Consumer Information (Cerner Multum)
- Halobetasol Topical application Advanced Consumer Information (Micromedex)
No comments:
Post a Comment